Association of the Breast Cancer Antiestrogen Resistance Protein 1 (BCAR1) and BCAR3 Scaffolding Proteins in Cell Signaling and Antiestrogen Resistance-Reference-Cited by-同舟云学术

Association of the Breast Cancer Antiestrogen Resistance Protein 1 (BCAR1) and BCAR3 Scaffolding Proteins in Cell Signaling and Antiestrogen Resistance

Published:2014-04 Issue:15 Volume:289 Page:10431-10444
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Wallez Yann,Riedl Stefan J.,Pasquale Elena B.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference72 articles.

1. Pathways to tamoxifen resistance;Riggins;Cancer letters.,2007

2. Biological determinants of endocrine resistance in breast cancer;Musgrove;Nat. Rev. Cancer.,2009

3. BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells;Brinkman;J. Natl. Cancer Inst.,2000

4. BCAR1/p130Cas expression in untreated and acquired tamoxifen-resistant human breast carcinomas;van der Flier;Int. J. Cancer.,2000

5. Bcar1/p130Cas protein and primary breast cancer. Prognosis and response to tamoxifen treatment;van der Flier;J. Natl. Cancer Inst.,2000

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCAR3 and BCAR3-related competing endogenous RNA expression in hepatocellular carcinoma and their prognostic value;World Journal of Gastrointestinal Oncology;2024-07-15

2. Deciphering the Role of BCAR3 in Cancer Progression: Gene Regulation, Signal Transduction, and Therapeutic Implications;Cancers;2024-04-26

3. Exploring the short linear motif-mediated protein-protein interactions of CrkL through ProP-PD;Biochemical and Biophysical Research Communications;2024-04

4. Exercise-induced redox modulation as a mediator of DNA methylation in health maintenance and disease prevention;Free Radical Biology and Medicine;2024-03

5. Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics;Clinical Proteomics;2023-11-08